Related Experiment Video
Updated: Aug 1, 2026

In Vivo Imaging Systems (IVIS) Detection of a Neuro-Invasive Encephalitic Virus
Published on: December 2, 2012
Intraventricular interferon-alpha stops seizures in Rasmussen's encephalitis: a case report
O Dabbagh1, G Gascon, J Crowell
1Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Rasmussen's encephalitis in a child was treated with intraventricular interferon-alpha, effectively controlling seizures refractory to multiple anticonvulsants. This novel treatment offers hope for managing this rare, severe neurological disorder.
Area of Science:
- Pediatric Neurology
- Neuroimmunology
Background:
- Rasmussen's encephalitis is a rare, chronic inflammatory neurological disease affecting one cerebral hemisphere, typically in children.
- It is characterized by progressive neurological deficits, including hemiparesis and intractable epilepsy.
Observation:
- A 3.5-year-old girl presented with epilepsia partialis continua, diagnosed as Rasmussen's encephalitis.
- Initial treatment with methylprednisolone provided only temporary seizure control.
Findings:
- The patient's seizures were refractory to a broad spectrum of conventional antiepileptic drugs over two years.
- Intraventricular interferon-alpha administration, in both a 6-week and a subsequent 6-month course, resulted in near-total seizure suppression.
Implications:
- Intraventricular interferon-alpha represents a promising therapeutic option for medically intractable Rasmussen's encephalitis.
- This approach may offer significant seizure control, improving neurological function and quality of life in affected children.
More Related Videos
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Arboviral Encephalitis
Inhibitors of Viral Protein Synthesis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

